Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis

J Antimicrob Chemother. 2019 Jul 1;74(7):2117-2118. doi: 10.1093/jac/dkz103.

Authors

Wesley D Kufel^{1

2

3}, Ambika P Eranki², Kristopher M Paolino², Andrea Call⁴, Christopher D Miller^{2

3}, Bryan T Mogle³

Affiliations

¹ Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USA.
² State University of New York Upstate Medical University, Syracuse, NY, USA.
³ State University of New York Upstate University Hospital, Syracuse, NY, USA.
⁴ Crouse Hospital, Syracuse, NY, USA.

PMID: 30863839
DOI: 10.1093/jac/dkz103

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacokinetics*
Boronic Acids / pharmacokinetics*
Chromatography, High Pressure Liquid
Continuous Renal Replacement Therapy*
Humans
Male
Meropenem / pharmacokinetics*
Middle Aged
Shock, Septic / drug therapy*
Shock, Septic / etiology*
Tandem Mass Spectrometry
Treatment Outcome

Substances

Anti-Bacterial Agents
Boronic Acids
vaborbactam
Meropenem